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Background: Diarrheal disease continues to be an important cause of morbidity and mortality among young
children in developing countries including Ethiopia. Globally, intestinal parasite, Shigella and Salmonella species
remain major contributors to acute enteric infections. The study was aimed at determining the frequency of
intestinal parasite, Shigella and Salmonella species identified from diarrheic children at Jimma Health Centre,
Jimma south west Ethiopia.
Methods: A health institution based cross sectional study was conducted from March to November 2012. A
structured questionnaire was used for collection of data on socio- demographic characteristics. Parasite and
bacteria identification as well as susceptibility testing was done using standard parasitological and bacteriological
procedures.
Results: A total of 260 diarrheal children were included in the study. A total of 129 (49.6%) samples were positive
for intestinal parasite, Shigella and Salmonella species. Of these, 107 (41.1%), 6 (2.3%) and 16 (6.2%) samples were
positive for intestinal parasite, Shigella and Salmonella species respectively. The dominant isolated parasite was
G. lamblia with prevalence of 13.5% followed by A. lumbricoides (11.5%). The least identified parasites were
Schistosoma mansoni and Taenia species accounting 0.4% each. Multiple parasitic infections were observed in 19
(7.3%) patients. Shigella species showed hundred percent resistances to ampicillin, amoxacillin, and cotrimoxazole.
All Salmonella isolates were resistant against amoxicillin. All Shigella and Salmonella species were susceptible to
ceftriaxone, ciprofloxacin and gentamycin.
Conclusion: The presence of reasonably high amount of intestinal parasite and Salmonella and Shigella species
that are drug resistance to the commonly prescribed drugs is a treat to the children and community at large.
Therefore, measures including health education, improvement of safe water supply, sanitation facilities and
continuous monitoring of microbiological and antimicrobial surveillance is crucial.
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Diarrheal disease continues to be an important cause of
morbidity and mortality among young children in devel-
oping countries [1]. Children and young adults are the
most affected, particularly in regions with limited resour-
ces and where hygienic measures are inadequate. Causes
of diarrhea in endemic areas include a wide variety of
bacteria, viruses, and parasites [2].
Gastrointestinal parasitic infections are amongst the
most common infections worldwide. These cases are
attributed to three common intestinal parasites: Ascaris
lumbricoides, hookworm, and Trichuris trichiura. The
global prevalence of parasitic diseases is estimated to be
478 million children for A. lumbricoides; 280 million for
hookworms and 347 million children for T. trichiura [3].
In Ethiopia, intestinal parasitic infections are of serious
public health concern [3]. According to a report by
the Ministry of Health, helminthiasis is the third lead-
ing cause of outpatient visits in health institutions in
2005-2006 [4].
Recently, it was observed that the prevalence of intes-
tinal parasitic infections in Jimma, Ethiopia [5] was as
high as 86.2%; whereas in Tigray, the overall prevalence
was 48.1% [6]. According to the study findings con-
ducted in Angolela, Ethiopia, on school children by
Nguyen et al (2012), one-third of the children were
infected with protozoan while 7.1% were found to have
helminthic infections [7].
Among the diarrhoeal pathogens, Shigella continues to
play a major role in etiology of inflammatory diarrhoea
and dysentery, thus presenting a serious challenge to
public-health authorities worldwide [8]. The few studies
conducted on shigellosis in Ethiopia revealed that,
Shigellosis and the emergence of antimicrobial resist-
ant Shigella species is a major health problem [9-14].
Recent data different health institutions in Ethiopia have
indicated that salmonellosis is a common problem and
also showed the presence of a number of serogroups/
serotypes in humans, animals, food animals, food prod-
ucts animal origins and other food stuff [15-19].
Infections by most species of Shigella and Salmonella
can be asymptomatic, or can be treated with rehydration
solutions except for infection by invasive strains. The
use of antibiotics might shorten the duration of diarrhea
and limit the shedding of the organisms which otherwise
might continue to spread among people and in to the
environment and further pose a risk of transmission of
infections. However, antimicrobial resistance is an over-
growing problem, and there is a need to monitor the
susceptibility of common bacterial isolates to drugs used
in the community to provide guidelines for the empirical
treatment of bacterial infections.
In the present study, a prospective cross sectional study
was conducted to determine the prevalence of intestineparasite, Shigella and Salmonella species among diahrroic
children visiting Jimma Helath Center from March to
November 2012, south West Ethiopia. We determined the
prevalence of intestinal parasites, Shigella and Salmonella
species in diarrhoeal stools of children including also the
susceptibility to antimicrobial agents of the investigated
pathogens.
Material and methods
Study design, area and period
A prospective cross sectional study was conducted to
determine the prevalence of intestinal parasite, Shigella
and Salmonella species among diarrheic children visiting
Jimma Health Center, Jimma south West Ethiopia from
March to November 2012.
Sample size and sampling technique
A total of 260 children were participated as a study
subject. The sample size was determined based on the
prevalence rate of the study done by Mache on children
at Jimma [15] and calculated with the formula recom-
mended by Daniel W [20].
Demographic data collection
Histories were taken from each child and informed
consent was obtained from the parents or guardians be-
fore sample collection was attempted by the attending
pediatrician. All relevant demographic, clinical and
laboratory data were recorded and transferred to the
questionnaire prepared for this study.
Specimen collection and identification of pathogens
Freshly passed stool and rectal swab was collected, placed
immediately in Cary Blair transport medium (Oxoid Ltd,
Basingstoke, UK) and transported to the laboratory within
six hours of collection. For identification of Shigella and
Salmonella species, specimens were placed in Selenite F
enrichment broth (Oxoid) and incubated at 37°C for 24
hours, then subcultured onto deoxycholate agar (DCA)
and xylose lysine deoxycholate agar (XLD) (Oxoid) agar at
37°C for 18-24 hours. The growth of Salmonella and
Shigella species was detected by their characteristic ap-
pearance on XLD agar (Shigella: red colonies, Salmonella
red with a black centre) and DCA (Shigella: pale colonies,
Salmonella black centre pale colonies). The suspected col-
onies were further tested through a series of biochemical
tests to identify Shigella and Salmonella species [21].
Parasitological examination of stool
Stool specimens were obtained from all participants and
examined for the presence of intestinal parasite cysts,
eggs, trophozoites and larvae. In the laboratory, slides
were prepared directly for wet mount in saline as well
as in iodine and then were microscopically examined
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field then under high-power (40X40 magnification) bright
field. Finally the sample was concentrated using the
procedure of formalin ethyl acetate technique4 and
iodine stained slides were prepared and examined
microscopically.
Susceptibility testing
Antimicrobial drug susceptibility testing was carried out
using disk diffusion method according to Clinical Labora-
tory Standards Institute (CLSI) guide lines [22]. The
antibiotic discs used and their concentrations were:-
ceftriaxone (CRO, 30 μg), chloramphenicol (C, 30 μg),
ciprofloxacin (CIP, 5 μg), gentamicin (GM, 10 μg), nali-
dixic acid (NA, 30 μg), trimethoprim-sulfamethoxazole/
cotrimoxazole (SXT, 25 μg) ampicillin (AMP 10 μg) and
amoxicillin (AML, 20 μg). All antibiotic were obtained
from Oxoid Limited, Basingstoke Hampshire, UK. A stan-
dard inoculum adjusted to 0.5 McFarland was swabbed
on to Muller- Hinton agar (Oxoid Ltd. Bashingstore
Hampaire, UK); antibiotic disc were dispensed after drying
the plate for 3-5 min and incubated at 37°C for 24 hours.
The reference strains used as control were E.coli ATCC
25922.
Data were entered and analyzed using SPSS version 16.0
computer software. Ethical clearance was secured from
Ethical Clearance Committee of College of Public Health
and Medical Sciences Jimma University. Permission was
obtained from Health center officials.
Results
Stool specimens of 260 children were collected and exam-
ined for the presence of intestinal parasites and cultured
for Salmonella and Shigella species. Out of the total
260 study participants 114 (43.8%) were males and
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Figure 1 Age and sex distribution of the study group.female ratio 1:0.8. The age of the studied children
ranges from one month of age to 15 years with mean
age of five year (+SD 4.1): the majority (60.3%) of the
study subjects were between 1-5 years of age and list
frequency (8.4%) was observed for children less than
one years old (Figure 1).
Out of the 260 stool samples, 129 (49.6%) samples were
positive for intestinal parasite, Shigella and Salmonella
species. Of these, 107 (41.1%), 6 (2.3%) and 16 (6.2%)
samples were positive for intestinal parasite, Shigella and
Salmonella species respectively. The dominant isolated
parasite was Giardia. lamblia with prevalence of 13.5%
followed by A. lumbricoides (11.5%). The least identified
parasites were Schistosoma mansoni and Taenia species
accounting 0.4% each (Table 1).
The distribution of enteropathogens according to the
different age groups is listed in Table 2. The majority
(58.1%) of enteropathogens were found in children aged
1−5 years. Whereas, 26 (20.2%), 21 (16.3%) and seven
(5.4%) pathogens were observed in children within age
groups of 6 – 10, 11 – 15 and less than one years,
respectively. Multiple parasitic infections were observed
in 19 patients (Table 3). Triple infection was observed in
five children (1.5%) and double parasitic infections were
observed among 14 children. The commonest parasites
in multiple infections were A. lumbricoides +G. lamblia.
The commonest double infections were T. trichuria +G.
lamblia +G. lamblia + E. histolytic. The commonest triple
infections were A. lumbricoides +H. nana +G. lamblia
(15.8%). There was no confection of bacteria (Salmonella
and Shigella species) and parasite among the children
(Table 3).
Shigella species showed hundred percent resistances to
ampicillin, amoxacillin, and cotrimoxazole while all (100%)
isolates were susceptible to ceftriaxone, ciprofloxacin
and gentamicin (Table 4). Resistance to ampicillin,21 2520 15
41 40





Table 1 Frequency of intestinal parasite and bacteria
isolated from 260 diarrheic children
Etiological pathogens Patient (n = 260) no. (%)
Paraite
A. lumbricoides 30 (11.5)
T. trichiura 8 (3.1)
Hook worm 4 (0.4)
H. nana 20 (7.5)
Taenia spp 1 (0.4)
S. mansoni 1 (0.4)
Giardia lamblia 35 (13.5)
E. histolytica 8 (3.1)
Total 107 (41.1)
Bacteria
Shigella species 6 (2.3)
Salmonella species 16 (6.2)
Total 22 (8.5)
Enteropahogens total 129 (49.6)
Table 3 Frequency of multiple (double and triple)
parasitic infections of children
Parasite combinations No %
As, Hy, GL 3 (15.8)
As, Tt, GL 1 (5.3)
As, Tt, EH 1 (5.3)
As, HW 2 (10.5)
As, Tt 2 (10.5)
As, GL 2 (10.5)
Hy, GL 2 (10.5)
Tt, GL 3 (15.8)
GL, Eh 3 (15.8)
Total 19 (100.0)
Keys: - Al- Ascaris lumbricoide, Hy: Hyminolopis nana, GL: Giardia lamblia,
Tt: Trichuris trichiuria, Eh: Entamoeba histolytica, HW: Hook worm.
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observed in 62.5, 31.3, 18.8% and 12.5 of Salmonella
isolate respectively. All Salmonella isolates were resist-
ant against Amoxicillin and susceptible to ceftriaxone,
ciprofloxacin and gentamicin (Table 4).
Over all three resistance patterns were seen among
Shigella isolates. All Shigella species were multi-drug
resistant (resistant to three or more antimicrobial drugs).
About 66.6% of Shigella species were resistant to three
(ampicillin, amoxacillin, cotrimoxazole) antibiotics. OnTable 2 Age distribution of intestinal parasite, Shigella
and Salmonella species among the study participants
No. (%)
Age group in years < 1 1–5 6–10 11–15
Parasite
A. lumbricoides - 13 (10.1) 10 (7.8) 7 (5.4)
T. trichiura - 5 (3.9) 1 (0.8) 2 (1.6)
Hook worm - 1 (0.8) 1 (0.8) 2 (1.6)
H. nana - 14 (10.9) 4 (3.1) 2 (1.6)
Taenia spp - - 1 (0.8) -
S. mansoni - - 1 (0.8) -
Giardia lamblilia - 28 (21.7) 3 (2.3) 4 (3.1)
E. histolytica 1 (0.8) 3 (2.3) 1 (0.8) 3 (2.3)
Bacteria
Shigella species 1 (0.8) 4 (3.1) 1 (0.8) -
Salmonella species 5 (3.9) 7 (5.4) 3 (2.3) 1 (0.8)
Total 7 (5.4) 75 (58.1) 26 (20.2) 21 (16.3)the other hand 62.5% of Salmonella species were multi-
drug resistant, ranging from 2 to 4 drugs (Table 5).
Discussion
The study results indicated, of the total 260 study par-
ticipants, 107 (41.1%) of the symptomatic children were
infected with one or more intestinal parasites. It is com-
parable with study done by Unasho in southern Ethiopia,
where 170 (41.9%) children were found to have single and
double intestinal parasitic infections [23], but higher than
study conducted in Gondar where the observed preva-
lence of intestinal parasites was 34.2% [24] and the study
conducted in Gamo area where 342 (39.9%) study subjects
were found positive for at least one intestinal parasite [25].
Our study prevalence result was lower compared with
reports of other similar studies, 72.9% in Gondar, Azezo
[25], 83% in Jimma [5] and 83.8% in South East of Lake
Langano [26]. These variations in prevalence might be
due to differences in climatic conditions, environmental
sanitation, economic and educational status of parents
and study subjects, and previous control efforts. The low
prevalence of intestinal parasite in this study compared toTable 4 Resistance pattern of Shigella and Salmonella
species
Antimicrobial No (%) of resistance
Shigella species (n = 6) Salmonella spices (n = 16)
Ampicillin 6 (100) 10 (62.5)
Amoxicillin 6 (100) 16 (100)
Cotrimethoxazole 6 (100) 5 (31.3)
Nalidixic acid 1 (16.7) 2 (12.5)
Ceftriaxone - -
Ciprofloxacin - -
Chloramphenicol 1 (16.7) 3 (18.8)
Gentamicin - -
Table 5 Antibiogram of Shigella and Salmonella isolates





Amp - 1 (6.3)
Amx - 5 (31.3)
Amp, Amx - 1 (6.3)
Amp, Amx, C - 1 (6.3)
Amp, Amx, Sxt 4 (66.6) 3 (18.8)
Amp, Amx, NA, - 2 (12.5)
Amp, Amx, Sxt, C 1 (16.7) 2 (12.5)
Amp, Amx, Sxt, NA, 1 (16.7) -
Keys:- Amp: Ampicillin, Amx: Amoxicillin, C: Chloramphenicol, NA: Nalidixic
acid, Sxt: Cotrimethoxazole.
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the country (7) could be due to increased awareness of the
community about personal and environmental hygiene
from the continuous awareness creation and interventions
made by the health science students from Jimma University
during their practical training conducted in the field as well
as in different health institutions.
Among helminthiasis, Ascaris lumbricoid (11.5%) was
the most prevalent parasite and followed by H. nana and
T.trichiura, whereas giardiasis was the leading infection
among protozoan infections. Though the rate of preva-
lence is different the dominancy of A. lumbricoides is in
line with the study result by Abayne in south Ethiopia
[23] and with previous studies done in Assedabo
(Jimma, Ethiopia), where Ascaris lumbricoides was the
leading (56.4%) [5]. But different with study conducted
in Gondar [24] where the dominant parasite was H. nana.
The difference could be mainly difference in climatic
condition.
Many studies had already demonstrated the high
prevalence of parasitic infections among Ethiopian chil-
dren in various parts of the country [5,27-29]. In this
study, A. lumbricoides (3.5%) and T. trichiura (3.1%)
were found to be the dominant soil transmitted hel-
minthes. Studies done by Ali et al. (1999) and Roma and
Solomon (1997) reported higher rates of A. lumbricoides
(54.6% vs. 75.2%) and T. trichiura (21% vs. 24.4%) res-
pectively [5,29]. Our study data showed comparable
prevalence rate with reported by Tadesse (2005) where
the prevalence rate of A. lumbricoides and T. trichiura
were 3.6% and 3.9%, respectively [30]. A prevalence rate
of 3% for H. nana is higher than earlier findings, which
were 1.1% in Wondogenet, Ethiopia [23], 1.3% in south
Wollo [31] and lower than with the findings of Tadesse,
(2005) and Haileamlak (2005) with frequency rate of
10.1% and 4.3% respectively [27,30].
Except in the early stage/age (where mostly rely on
breast feeding), parasitic infections were decreasing asthe age of the children increases, which could be due to
acquired immunity as they are exposed more and more
to infections as well as developing awarness to personal
hygiene. In this study multiple parasitic infections were
seen in 19 children (7.3%) from the total 260 study sub-
jects and 17.8% among children who were infected with
parasites and this result is higher than the study con-
ducted in Gondar, where multiple infections (polypara-
sitism) occurred in 14 individuals or 4.6% of the total
examined subjects and 13.5% of those who had intestinal
parasites [32]. The difference could be due to geograph-
ical location or variation in study subject sample size.
Comparison with previous study results conducted in
different parts of Ethiopia is difficult since the parasite
prevalence varies with agro-ecozone, altitude and other en-
vironmental factors which are not studied here. Shigellosis
is primary a pediatric disease, with more than half of
all infections occurring in children between six month
to 10 years of age as observed in previous Ethiopian study
[14]. The isolation of Shigella species (2.3%) in this study
is lower than (5%) reported by Mache, 2001 [14] (20.1%)
from the same study subjects and area.
Even though, the study was conducted in different age
groups, our prevalence rate of 2.3% lowers than that a
report by Ashenafi, 1983 (9%) [33] and 11.7% isolation
rate reported by Asrat et al. 1999 at Tikur Anbessa,
Ethio-Swedish children’s hospital [34], a report by Ayalu
(6.7%) in Harar [35] and a report 15.6% by Hiruy in
Gondar [36]. The low isolation of Shigella in this study
compared to the previous study in Jimma (14) could be
due to increased awareness of the community about per-
sonal and environmental hygiene from the continuous
interventions made by the health science students form
Jimma University during their filed practice.
Epidemiological investigation of salmonellosis in deve-
loping countries like Ethiopia is difficult because of the
very limited scope of the studies and lack of coordinated
surveillance systems. The overall prevalence of Salmonella
in this study was 6.2%. This is comparable with studies
conducted in Ethiopia at different times, 4.5% in Addis
Ababa [37], 6.4% in Addis Ababa [16], 4.5% in Addis
Ababa [33] and higher than the findings reported by Asrat
et al. 1999 (3.8%) in Addis Ababa [34] but lower than
reported in Jimma (15%) [15]. Antibiotic susceptibility
data to Shigella isolates showed that all isolates were
resistance to ampicillin, amoxacillin, and cotrimoxazole.
Similarly a study conducted in Awassa showed that all
isolates were resistant to amoxacillin and ampicillin (12).
The development of high resistance of Shigella species
against the commonly used antibiotics was witnessed by
other investigators in different periods. In Hawassa high
rate of resistance of Shigella species to ampicillin (93%),
erythromycin (90%), tetracycline (90%) and cotrimoxazole
(56%) was reported by Roma et al [12], in Gondar, high
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(79.9%), tetracycline (86%), and cotrimoxazole (73.4%)
by Yismaw et al. [38]. Asrat reported isolation of Shigella
species with high resistance to erythromycin (100%),
Tetracycline (97.3%), and ampicillin (78.7%) in Addis
Ababa [39]. High resistance against amoxicillin (100%)
and ampicillin (100%) was also reported by Reda et al. in
Harar [35]. Our Shigella isolates were highly susceptible to
ceftriaxone, ciprofloxacin and gentamicin. Comparatively
high rate of resistance to ciprofloxacin (8.3%) was reported
in Gondar. In parallel to our result lower (2%) resistance
rate was reported from Gondar [38]. Comparable to the
study conducted by Daniel [39] in Addis Ababa where all
Shigella isolates were susceptible to gentamicin. The low
resistant rate of isolates to chloramphenicol (18.8%), could
be that physicians stopped to prescribe the drug before
long time a go and once again the strains started to
become sensitive. All Shigella isolates were MDR (resist-
ant to two or more drugs). Similar findings were seen in
other studies in Ethiopia [12,38].
Infection with non-typhoidal Salmonella in infants and
children commonly produces self-limited diarrhoea.
Studies have indicated that antimicrobial treatment for
uncomplicated gastroenteritis does not shorten the dur-
ation and severity of symptoms; in contrast, it may pro-
long fecal excretion, increase the risk of relapse, and result
in the emergence of antibiotic resistance [40]. Never-
theless, if extra-intestinal complications occur, effective
antimicrobial treatment is essential. Multidrug resistant
phenotypes have been increasingly described among
Salmonella species worldwide, according to the infectious
disease report released by the WHO in 2000 [41].
In this study, Salmonella isolates showed high re resis-
tant to ampicillin and amoxicillin which is comparable
with previous study done in Harar, Ethiopia where the
highest level of resistance was detected to ampicillin
(100%) and amoxicillin (100%) [35]. a relatively similar
pattern of resistance (74 to 97.3%) was reported from
other parts of the country [42] and outside [43]. Our
study findings showed that all Salmonella species were
susceptible to ceftriaxone and ciprofloxacin, which is
inline with recently study results conducted in Nigeria
where all isolates were susceptible to ciprofloxacin, and
ceftriaxone [44]. Un like most previous study findings, in
this study Shigella and Salmonella species showed low
resistance level to chloramphenicol, this could be due
abandoning of prescribing the drug by the responsible
health personnel before a long time ago.
Conclusion
This study indicated that intestinal parasite and some
enteric bacteria such as Salmonella and Shigella species
are responsible for the majority cases of diarrhoel in
children. The results of the present study suggested thatantibiotics which were more commonly prescribed in
the study area previously, like ampicillin, amoxicillin and
cotrimethoxazole developed resistance to Shigella and
Salmonella species and should not be used as empirical
treatment of diarrhoea in children at least in the study
area. Therefore, measures including health education,
improvement of safe water supply, sanitation facilities
and continuous monitoring of microbiological and anti-
microbial surveillance is crucial.
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